Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.

Kangstem Biotech

Status: Unknown

Conditions: Atopic Dermatitis

Study type: Observational

Funder types: Industry

Identifiers

NCT03458624

KSTHD_FURESTEM_AD_EXT

Details and patient eligibility

About

Observational Study to Assess the Safety and Efficacy of FURESTEM-AD lnj. In moderate to Atopic Dermatitis

Full description

This is a observational study, single center, open label, study of safety and Efficacy of FURESTEM-AD Inj. in subjects with moderate to severe Atopic Dermatitis.

Enrollment: 14 patients

Sex: All

Ages: 19 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects participating in this observational study originally participated in study FURESTEM-RA Inj.[NCT02221258]
• Subject who understands and voluntarily sign an informed consent form

Exclusion criteria

• In case follow-up is not possible from end of clinical trial Phase 1/2a to end of this study period

Trial design

14 participants in 1 patient group

Not applicable-observational study

Description:

Not applicable-observational study